Elevance Health
Stock Forecast, Prediction & Price Target

Elevance Health (ELV) stock Price Target by analysts

Last Year
Average Price Target

$525.33

Potential upside: 68.71%

Based on 6 analysts

Elevance Health price prediction

Strike.market

What is Elevance Health stock analysts` prediction?

Elevance Health stock forecast: Based on 6 Wall Street analysts` predicted price targets for Elevance Health in the last 3 months, the avarage price target is $525.33, with a high forecast of $NaN. The average price target represents a 68.71% change from the last price of $311.38.

Disclaimer: This is not investment advice. Don't use price targets as the only investment indicator. Always remember to do your own thorough research and due diligence before making an investment decision.

Elevance Health stock Price Target by analysts

Full breakdown of analysts given Elevance Health price targets

Analyst name & company
Analyst win rate
Publish date
Price target
Price when posted
Source Historical targets
David Windley
Jefferies
0%
0/3
10 months ago $529 69.88% upside $430.77 StreetInsider
Previous targets (2)
Whit Mayo
Leerink Partners
0%
0/1
10 months ago $515 65.39% upside $430.77 StreetInsider
Previous targets (0)
Ben Hendrix
RBC Capital
20%
1/5
11 months ago $478 53.51% upside $444.35 StreetInsider
Previous targets (4)
Sarah James
Raymond James
0%
0/1
11 months ago $485 55.75% upside $432.53 Benzinga
Previous targets (0)
David MacDonald
Truist Financial
0%
0/3
11 months ago $520 66.99% upside $444.35 StreetInsider
Previous targets (2)
Michael Ha
Robert W. Baird
0%
0/2
11 months ago $625 100.71% upside $483.87 StreetInsider
Previous targets (1)
Ben Hendrix
RBC Capital
20%
1/5
about 1 year ago $585 87.87% upside $502.06 TheFly
Previous targets (4)
David MacDonald
Truist Financial
0%
0/3
about 1 year ago $620 99.11% upside $535.54 TheFly
Previous targets (2)
Erin Wright
Morgan Stanley
0%
0/1
about 1 year ago $643 106.50% upside $534.42 TheFly
Previous targets (0)
Michael Ha
Robert W. Baird
0%
0/2
over 1 year ago $649 108.42% upside $505.52 TheFly
Previous targets (1)
Ben Hendrix
RBC Capital
20%
1/5
over 1 year ago $575 84.66% upside $525.19 StreetInsider
Previous targets (4)
Stephen Baxter
Wells Fargo
0%
0/2
over 1 year ago $600 92.69% upside $525.19 StreetInsider
Previous targets (1)
AJ Rice
UBS
0%
0/1
over 1 year ago $605 94.29% upside $525.19 StreetInsider
Previous targets (0)
Andrew Mok
Barclays
0%
0/1
over 1 year ago $621 99.43% upside $525.19 TheFly
Previous targets (0)
David Windley
Jefferies
0%
0/3
over 1 year ago $604 93.97% upside $525.19 StreetInsider
Previous targets (2)
Unknown
Mizuho Securities
N/A
almost 3 years ago $575 84.66% upside $521.88 Benzinga
N/A
Joseph France
Loop Capital Markets
0%
0/1
about 3 years ago $550 76.63% upside $454.76 TheFly
Previous targets (0)
Stephen Baxter
Wells Fargo
0%
0/2
over 3 years ago $580 86.26% upside $501.53 Pulse 2.0
Previous targets (1)
Unknown
BMO Capital
N/A
over 3 years ago $625 100.71% upside $495.61 Benzinga
N/A
Unknown
Deutsche Bank
N/A
over 3 years ago $574 84.34% upside $510.41 Benzinga
N/A
Ben Hendrix
RBC Capital
20%
1/5
over 3 years ago $544 74.70% upside $522.87 StreetInsider
Previous targets (4)
Jonathan Yong
Credit Suisse
0%
0/1
over 3 years ago $584 87.55% upside $522.87 StreetInsider
Previous targets (0)
Unknown
Leerink Partners
N/A
over 3 years ago $555 78.23% upside $529.84 Benzinga
N/A
Unknown
Goldman Sachs
N/A
over 3 years ago $605 94.29% upside $529.84 Benzinga
N/A
Unknown
Morgan Stanley
N/A
over 3 years ago $607 94.93% upside $528.45 Benzinga
N/A
Michael Newshel
Evercore ISI
100%
2/2
over 3 years ago $335 7.58% upside $529.84 TipRanks Contributor
Previous targets (1)
Ann Hynes
Mizuho Securities
100%
1/1
over 3 years ago $510 63.78% upside $529.84 TipRanks Contributor
Previous targets (0)
David Windley
Jefferies
0%
0/3
over 3 years ago $625 100.71% upside $529.84 TipRanks Contributor
Previous targets (2)
David MacDonald
Truist Financial
0%
0/3
over 3 years ago $590 89.47% upside $510.64 Pulse 2.0
Previous targets (2)
Kevin Caliendo
UBS
100%
1/1
over 3 years ago $541 73.74% upside $489.34 Pulse 2.0
Previous targets (0)
Matthew Borsch
BMO Capital
100%
1/1
over 3 years ago $510 63.78% upside $434.61 StreetInsider
Previous targets (0)
Lisa Gill
J.P. Morgan
100%
1/1
over 3 years ago $500 60.57% upside $434.61 TipRanks Contributor
Previous targets (0)
Ben Hendrix
RBC Capital
20%
1/5
over 3 years ago $452 45.16% upside $434.61 TipRanks Contributor
Previous targets (4)
Michael Newshel
Evercore ISI
100%
2/2
over 3 years ago $335 7.58% upside $427.24 TipRanks Contributor
Previous targets (1)
Joseph France
Seaport Global
100%
1/1
over 3 years ago $480 54.15% upside $427.24 StreetInsider
Previous targets (0)
Lance Wilkes
Bernstein
0%
0/1
over 3 years ago $574 84.34% upside $452.46 TheFly
Previous targets (0)
Steve Baxter
Wells Fargo
100%
1/1
over 3 years ago $523 67.96% upside $438.22 TipRanks Contributor
Previous targets (0)
Nathan Rich
Goldman Sachs
100%
1/1
over 3 years ago $517 66.03% upside $432.72 TheFly
Previous targets (0)
Justin Lake
Wolfe Research
100%
1/1
almost 4 years ago $433 39.05% upside $403.96 StreetInsider
Previous targets (0)
Steven Valiquette
Barclays
100%
1/1
almost 4 years ago $485 55.75% upside $428 TheFly
Previous targets (0)
Kevin Fischbeck
Bank of America Securities
100%
1/1
almost 4 years ago $465 49.33% upside $428 StreetInsider
Previous targets (0)
A.J. Rice
Credit Suisse
100%
1/1
almost 4 years ago $486 56.07% upside $428 StreetInsider
Previous targets (0)
Steven Halper
Cantor Fitzgerald
100%
1/1
almost 4 years ago $470 50.94% upside $421.68 StreetInsider
Previous targets (0)

Elevance Health Financial Estimates

Elevance Health Revenue Estimates

Elevance Health EBITDA Estimates

Elevance Health Earnings per Share Estimates

Passed Analyst forecast
Metric 12/31/2021 12/31/2022 12/31/2023 12/31/2025 12/31/2026 12/31/2027
Revenue
 
% change YoY
$138.63B
 
N/A
$156.59B
 
12.95%
$171.34B
 
9.41%
Avg: $182.32B
Low: $178.30B
High: $187.66B
avg. 6.41%
Avg: $194.23B
Low: $191.18B
High: $198.39B
avg. 6.53%
Avg: $228.34B
Low: $224.75B
High: $233.23B
avg. 17.56%
Net Income
 
% change YoY
$6.15B
 
N/A
$5.89B
 
-4.28%
$5.98B
 
1.57%
Avg: $9.06B
Low: $8.83B
High: $9.57B
avg. 51.49%
Avg: $9.91B
Low: $10.13B
High: $10.82B
avg. 9.29%
Avg: $12.74B
Low: $12.48B
High: $13.10B
avg. 28.60%
EBITDA
 
% change YoY
$9.22B
 
N/A
$9.44B
 
2.35%
$10.49B
 
11.07%
Avg: $9.69B
Low: $9.48B
High: $9.98B
avg. -7.53%
Avg: $10.33B
Low: $10.17B
High: $10.55B
avg. 6.53%
Avg: $12.14B
Low: $11.95B
High: $12.40B
avg. 17.56%
EPS
 
% change YoY
$25.04
 
N/A
$24.56
 
-1.91%
$25.69
 
4.60%
Avg: $39.49
Low: $37.2
High: $40.35
avg. 53.72%
Avg: $44.53
Low: $42.71
High: $45.61
avg. 12.75%
Avg: $53.7
Low: $52.6
High: $55.2
avg. 20.59%
Operating Expenses
 
% change YoY
$15.91B
 
N/A
$17.68B
 
11.13%
$36.23B
 
104.88%
Avg: $25.95B
Low: $25.38B
High: $26.71B
avg. -28.36%
Avg: $27.65B
Low: $27.22B
High: $28.24B
avg. 6.53%
Avg: $32.51B
Low: $32.00B
High: $33.20B
avg. 17.56%

FAQ

What is Elevance Health stock earnings growth forecast?

Wall Street analysts estimate the annual average earnings growth rate of 29.79% in 2025-2027.

We have gathered data from 15 analysts. Their low estimate is 8.83B, average is 9.06B and high is 9.57B.

What is Elevance Health stock revenue growth forecast?

Wall Street analysts forecast annual average revenue growth of 10.16% in 2025-2027.

We have gathered data from 16 analysts. Their low revenue estimate is $178.30B, average is $182.32B and high is $187.66B.

What is Elevance Health stock earnings per share growth forecast?

Wall Street analysts forecast annual average earnings growth of 29.02% in 2025-2027.

We have gathered data from 15 analysts. Their low earnings per share estimate is $37.2, average is $39.49 and high is $40.35.

What is the best performing analyst?

In the last twelve months 6 analysts have been covering Elevance Health stock. The most successful analyst is David Windley.